Do you have space in your income portfolio for some ASX dividend stocks? If you do, then it could be worth checking out the three in this article.
They have recently been recommended as buys by brokers in March. Here's why they could be top picks for income investors with $3,000 to put to work in the share market:
Image source: Getty Images
Cedar Woods Properties Limited (ASX: CWP)
Bell Potter thinks Cedar Woods could be an ASX dividend stock to buy this month.
It is one of Australia's leading property companies, owning a high-quality portfolio that is diversified by geography, price point, and product type. The broker believes that this leaves it well-positioned to be a big winner from Australia's chronic housing shortage.
Bell Potter expects this to support dividends per share of 39 cents in FY 2026 and then 41 cents in FY 2027. Based on its current share price of $8.73, this equates to 4.5% and 4.7% dividend yields, respectively.
The broker has a buy rating and $10.20 price target on its shares.
Premier Investments Ltd (ASX: PMV)
Another ASX dividend stock to consider for income is Premier Investments.
It is the owner of popular retail brands Smiggle and Peter Alexander, as well as a sizeable stake in appliance manufacturer Breville Group Ltd (ASX: BRG). These assets are consistently generating strong free cash flow, which is usually returned to shareholders in the form of dividends.
Macquarie is positive on this one, especially given its belief that the Peter Alexander brand is being significantly undervalued.
As for income, it expects fully franked dividends of 79 cents per share in FY 2026 and then 90.3 cents per share in FY 2027. Based on its current share price of $12.87, this equates to dividend yields of 6.1% and 7%, respectively.
The broker currently has an outperform rating and $16.20 price target on the shares.
Sonic Healthcare Ltd (ASX: SHL)
A final ASX dividend stock to consider according to analysts is Sonic Healthcare.
It is a global medical diagnostics company, operating laboratories and collection centres across Australia, Europe, and the United States. Its services are tied to healthcare demand rather than economic cycles, which can provide a degree of earnings resilience.
Macquarie is also positive on this one and is recommending Sonic Healthcare to clients.
The broker recently put an outperform rating and $27.50 price target on its shares.
In terms of income, Macquarie is forecasting partially franked dividends of 104 cents per share in FY 2026 and 100 cents per share in FY 2027. Based on the current share price of $23.01, this implies dividend yields of 4.5% and 4.35%, respectively.
